1
Sullivan John K, Mcgivern Joseph G, Miranda Leslie P, Nguyen Hung Q, Walker Kenneth W, Hu Shaw Fen Sylvia, Gegg Colin V Jr, Arora, Khare Taruna, Adler Beverly S, Martin Francis H: Toxin peptide therapeutic agents. Amgen, Sullivan John K, Mcgivern Joseph G, Miranda Leslie P, Nguyen Hung Q, Walker Kenneth W, Hu Shaw Fen Sylvia, Gegg Colin V Jr, Arora, Khare Taruna, Adler Beverly S, Martin Francis H, STEINBERG Nisan A, July 24, 2008: WO/2008/088422 (19 worldwide citation)

Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of ...


2
Fox Gary M, Sullivan John K, Fang Mei: B7-like molecules and uses thereof. Amgen, Fox Gary M, Sullivan John K, Fang Mei, ZUHN Donald L, January 10, 2002: WO/2002/002624 (3 worldwide citation)

The present invention provides B7-Like(B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7-L polypeptides. The invention further provides pharmaceutical compositions and methods for t ...


3
Fox Gary Michael, Sullivan John K, Holst Paige, Yoshinaga Steven Kiyoshi: B7-like molecules and uses thereof. Amgen, Fox Gary Michael, Sullivan John K, Holst Paige, Yoshinaga Steven Kiyoshi, ZUHN Donald L, March 28, 2002: WO/2002/024891 (1 worldwide citation)

The present invention provides B7-Like(B7-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing B7-L polypeptides. The invention further provides pharmaceutical compositions and methods for t ...


4
Boyle William J, Medlock Eugene, Sullivan John K, Elliott Robin L, Martin Francis Hall, Huang Haichun: Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors. Amgen, Boyle William J, Medlock Eugene, Sullivan John K, Elliott Robin L, Martin Francis Hall, Huang Haichun, NOONAN Kevin E, October 23, 2003: WO/2003/086289

Monoclonal antibodies and hybridomas producing them that interact with osteoprotegerin ligand (OPGL) are provided. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are also provided. Methods of detecting the amount of OPGL in a sampl ...